| Literature DB >> 33498571 |
Dorota Skrzypczak1, Alicja Ewa Ratajczak1, Aleksandra Szymczak-Tomczak1, Agnieszka Dobrowolska1, Piotr Eder1, Iwona Krela-Kaźmierczak1.
Abstract
Sarcopenia is a disorder characterized by a loss of muscle mass which leads to the reduction of muscle strength and a decrease in the quality and quantity of muscle. It was previously thought that sarcopenia was specific to ageing. However, sarcopenia may affect patients suffering from chronic diseases throughout their entire lives. A decreased mass of muscle and bone is common among patients with inflammatory bowel disease (IBD). Since sarcopenia and osteoporosis are closely linked, they should be diagnosed as mutual consequences of IBD. Additionally, multidirectional treatment of sarcopenia and osteoporosis including nutrition, physical activity, and pharmacotherapy should include both disorders, referred to as osteosarcopenia.Entities:
Keywords: Crohn’s disease; IBD; low muscle mass; low muscle strength; malnutrition; nutritional therapy; sarcopenia; ulcerative colitis
Mesh:
Substances:
Year: 2021 PMID: 33498571 PMCID: PMC7909530 DOI: 10.3390/nu13020293
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717